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Abstract
Bone marrow-derived mesenchymal stem cells (BM-MSCs) are multipotent stromal cells that have a
critical role in the maintenance of skeletal tissues such as bone, cartilage, and the fat in bone marrow. In
addition to providing microenvironmental support for hematopoietic processes, BM-MSCs can
differentiate into various mesodermal lineages including osteoblast/osteocyte, chondrocyte, and
adipocyte that are crucial for bone metabolism. While BM-MSCs have high cell-to-cell heterogeneity in
gene expression, the cell subtypes that contribute to this heterogeneity in vivo in humans have not been
characterized. To investigate the transcriptional diversity of BM-MSCs, we applied single-cell RNA
sequencing (scRNA-seq) on freshly isolated CD271+ BM-derived mononuclear cells (BM-MNCs) from
two human subjects. We successfully identified LEPRhiCD45low BM-MSCs within the CD271+ BM-MNC
population, and further codified the BM-MSCs into distinct subpopulations corresponding to the
osteogenic, chondrogenic, and adipogenic differentiation trajectories, as well as terminal-stage quiescent
cells. Biological functional annotations of the transcriptomes suggest that osteoblast precursors induce
angiogenesis coupled with osteogenesis, and chondrocyte precursors have the potential to differentiate
into myocytes. We also discovered transcripts for several clusters of differentiation (CD) markers that
were either highly expressed (e.g., CD167b, CD91, CD130 and CD118) or absent (e.g., CD74, CD217,
CD148 and CD68) in BM-MSCs, representing potential novel markers for human BM-MSC purification.
This study is the first systematic in vivo dissection of human BM-MSCs cell subtypes at the single-cell
resolution, revealing an insight into the extent of their cellular heterogeneity and roles in maintaining
bone homeostasis.
Key words: single-cell RNA sequencing (scRNA-seq); mesenchymal stem cell (MSC); bone marrow; osteogenesis;
chondrogenesis; adipogenesis
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Introduction
The human bone tissue is a complex system that
consists of diverse cell types including osteoblast/
osteocyte, osteoclast, and chondrocyte (collectively
known as “bone cells”), together with various
supporting cells such as adipocyte, fibroblast, and
hematopoietic cells among others. A delicate balance
of bone formation/resorption is critical for
maintaining bone health, and therefore bone cells
must work together to maintain bone strength and
mineral homeostasis. Despite the extensive study of
bone cells, their underlying biology remains poorly
understood. While osteoclasts are of hematopoietic
origin and derived from the “monocyte/macrophagepreosteoclast-osteoclast” differentiation trajectory [1],
the detailed origins of osteoblast/osteocyte and
chondrocyte are not as well characterized.
Currently, cells that give rise to osteoblast/
osteocyte, chondrocyte, and adipocyte are generally
referred to as “mesenchymal stromal/stem cells”
(MSCs), which are non-hematopoietic bone marrow
stromal cells with fibroblast colony-forming unit
(CFU-F) and multi-differentiation capacity [2].
Typically, the human bone-marrow derived MSCs
(BM-MSCs) are isolated with a combination of
non-specific cell-surface markers such as high level of
CD271, CD44, CD105, CD73, CD90, and low
level/absence of CD45, CD34, CD14 or CD11b, CD79a
or CD19, and human leukocyte antigen HLA-DR [3,4].
Among these markers, CD271 shows great efficiency
to sort MSCs either alone or in combination with
negative selection of markers such as CD45 [5,6].
Additionally, LEPR (leptin receptor, or CD295) is used
for isolating BM-MSCs in transgenic labeling mice
[7,8]. Although these cell markers are candidates for
isolating BM-MSCs, recent evidence suggests that the
BM-MSCs are a heterogeneous group of cells for some
cell markers. For instance, Akiyama et al. [9]
demonstrated that a small portion of BM-MSCs
express CD45 and CD34, which are traditionally
regarded as negative markers. Meanwhile, some
studies also suggested that only around 50% of MSCs
are positive for CD105 [10,11], a cell marker
previously considered universally expressed by MSCs
derived from different tissue [12].
The extent of the cellular heterogeneity among
the BM-MSCs is not well-defined, although a few
studies have proposed some novel subtypes. One
study reported a subset of cultured mouse BM-MSCs
that are distinct from regular BM-MSCs based upon
differential attachment to plastic culture dishes,
proliferation, and self-renewal patterns [9]. Another
study examining cultured human BM-MSCs
demonstrated that CD264 marks a subpopulation of
aging human BM-MSCs with differential fibroblast
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colony forming efficiency [13]. Several other efforts
have attempted to deconvolute the heterogeneity of
BM-MSCs through the identification of the
differentiation trajectory associated with a given
subpopulation. For example, one study found that
effective chondrocyte differentiation could only be
induced in human MSCA-1+CD56+ BM-MSCs, while
adipocytes are derived only from MSCA-1+CD56−
BM-MSCs in vitro [14]. Another study identified
“skeletal stem cells” in both mice and humans, which
give rise to bone, stroma, and cartilage cells in vivo in
mice, but not adipocytes or myocytes [15,16].
Single-cell RNA sequencing (scRNA-seq) has
recently emerged as a powerful approach to study cell
heterogeneity in complex tissues. scRNA-seq
measures transcriptional profiles of many cells at
single-cell resolution, which can be clustered to
distinguish and classify cell subtypes, infer
developmental trajectories, and identify novel
regulatory
mechanisms
[17,18].
scRNA-seq
technology represents a major advancement beyond
the conventional bulk RNA-seq transcriptomics
approach which attempts to infer biological
mechanisms from average gene expression, weighted
by the unknown proportions of unknown cell
subtypes, across a heterogeneous cell population.
Several studies have applied scRNA-seq to bone
marrow stroma cells. However, these studies were
either conducted in mice [7,19] or cultured cells from
human subjects [20,21], which may not accurately
represent the transcriptional profile of human
primary BM-MSCs in vivo [22,23].
Our current work is the first systematic
scRNA-seq analysis of freshly isolated human CD271+
bone marrow mononuclear cells (BM-MNCs). We
have successfully identified LEPRhiCD45low BM-MSCs
in the CD271+ BM-MNC population and further
revealed distinct subpopulations in LEPRhiCD45low
BM-MSCs
along
with
their
differentiation
relationships and functional characteristics. By
comparing the expression pattern of LEPRhiCD45low
BM-MSCs with CD45hi hematopoietic cells, we have
also identified several potential novel markers for
human BM-MSC purification. Our findings provide
significant insight into the identities and complexities
of human BM-MSCs in vivo.

Methods
Study population
The clinical study was approved by the Medical
Ethics Committee of Central South University, and
written informed consents were obtained from each
participant. The study population consists of two
Chinese subjects who underwent hip replacement
http://www.ijbs.com
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surgery at the Xiangya Hospital of Central South
University in 2019, including one 84-year-old male
with osteoarthritis and normal bone mineral density
(BMD; BMD T-score: -0.9 at lumbar vertebrae, 2.7 at
total hip) and one 67-year-old female with
osteoporosis (BMD T-score: -3.3 at lumbar vertebrae,
-3.7 at total hip). Study participants were screened
prior to surgery based on a detailed questionnaire,
medical history, and a physical examination. Subjects
were excluded from the study if they had preexisting
chronic conditions which may influence bone
metabolism including diabetes mellitus, renal failure,
liver failure, hematologic diseases, disorders of the
thyroid/parathyroid,
malabsorption
syndrome,
malignant tumors, and previous pathologic fractures
[24]. During hip replacement surgery, surgeons
collected the bone marrow from the femoral shafts
from each subject and transferred the samples to our
laboratory immediately following the procedure. The
samples were stored at 4 °C and processed within 24
hours after collection.

Experimental animals
Female C57BL/6J mice were purchased from
Jackson Laboratory (Bar Harbor, ME, USA). All mice
were housed in pathogen-free conditions and fed with
autoclaved food, and all experimental procedures
were approved by the Ethics Committee of Xiangya
Hospital of Central South University.

BMD measurement
BMD (g/cm2) at the lumbar spine (L1-L4) and
the total hip (femoral neck and trochanter) were
measured with a duel energy x-ray absorptiometry
(DXA) fan-beam bone densitometer (Hologic QDR
4500A, Hologic, Inc., Bedford, MA, USA). According
to the World Health Organization definition [25] and
the BMD reference established for Chinese
populations [26], subjects with a BMD of 2.5 SDs
lower than the peak mean of the same gender (T-score
≤ -2.5) were determined to be osteoporotic, while
subjects with -2.5 < T-score < -1 are classified as
having osteopenia and subjects with T-score > -1.0 are
considered healthy.

Human bone marrow cell dissociation
Bone marrow derived mononuclear cells
(BM-MNCs) were extracted from the marrow cavity
of femoral shafts using a widely applied dissociation
protocol 5,6]. Briefly, the bone marrow was attenuated
with PBS (1:2) and mixed gently. The mixture was
then equally layered onto equal volume of Ficoll (GE
health care, Chicago, IL, USA), and the buffy coat was
isolated by centrifugation (440 g, 35 min, 4 °C). The
separated buffy coat was transferred into a new 15 ml
centrifuge tube and washed with PBS. After
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discarding the supernatant, red blood cells were lysed
with RBC Lysis Buffer (Thermo Fisher, Waltham, MA,
USA). After washing twice with PBS, the remaining
MNCs were further purified with CD271 magnetic
MicroBeads (Miltenyi Biotec, Bergisch Gladbach,
Germany) for positive selection [6].

Positive selection of human CD271+ BM-MNC
BM-MNCs were incubated for 10 min at 4-8 °C
with monoclonal antibody (mAb) against CD271.
After washing, the cells were incubated with
anti-IgG1 immunomagnetic beads for 15 min at 4 °C.
The cell suspension was placed on a column in a cell
separator (Miltenyi Biotec), and the positive fraction
was subjected to a second separation step. The cells
were then counted and assessed for viability with a
Countstar® Rigel S3 fluorescence cell analyzer (ALIT
Life Science Co., Ltd, Shanghai, China).

Isolation of murine BM-MSCs
Cells were isolated from flushed bone marrow
from female C57BL/6 mice (8 weeks) and dissociated
using 21G needle. Cells were then plated in 75-cm2
cell culture flasks containing 10 mL of MesenCultTM
basal expansion medium with 10× Supplement
(Stemcell, Vancouver, Canada), 100 U/mL penicillinstreptomycin, L-glutamine 2 mM, and incubate at 37
°C 5% CO2 for one week. 0.1% MesenPureTM
(Stemcell) was added for the depletion of CD45+ cells.
Stromal cells were allowed to reach 80%-90%
confluency before passage or planting.

Flow cytometry
Cells were resuspended in 100 μL of staining
medium, followed by staining with fluorochromeconjugated antibodies on ice for 20 minutes. The
antibodies used in this study to identify MSCs were
anti-CD45-FITC (eBioscience, clone 30-F11, 0.5
µg/test), anti-Ter119-FITC (eBioscience, clone TER119, 0.25 µg/test), anti-CD31-FITC (eBioscience, clone
390, 1 µg/test), and anti-CD56-PE (R&D Systems,
clone # 809220, 0.5 µg/test). Cells were analyzed on a
Sony MA900 Cell Sorter, where CD45/Ter119/CD31cells were identified as BM-MSCs, and CD56 was
used to separate CD56+ and CD56- cell subtypes.

Bone sectioning, immunostaining, and
confocal imaging
Freshly dissected bones were fixed in 4%
paraformaldehyde
overnight,
followed
by
decalcification in 10% EDTA for 1 week, and then
dehydrated using a series of graded ethanol and
embedded in paraffin. Samples were then cut into
5-µm-thick
longitudinally
oriented
sections,
deparaffinized in xylene, and rehydrated in
decreasing concentrations of ethanol followed by
http://www.ijbs.com
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distilled water. After deparaffinization and antigen
retrieval, sections were blocked in PBS with 5%
bovine serum albumin (BSA) for 1 hour and then
stained overnight with the following primary
antibodies: goat-anti-LepR (R&D: AF497, 10 µg/mL)
and rabbit-anti-CD56 (Proteintech: 14255-1-AP,
1:2000). Next, samples were incubated with
appropriate secondary antibodies, including donkey
anti-goat Alexa Fluor 555 and donkey anti-rabbit
Alexa Fluor 647 (all from Invitrogen, 1:400). Slides
were mounted with anti-fade prolong gold
(Invitrogen) and images were acquired with a Zeiss
LSM780 confocal microscope.

Cell capture and cDNA synthesis
After isolation of human CD271+ BM-MNCs, we
applied the Chromium single cell gene expression
platform (10x Genomics, Pleasanton, CA, USA) for
scRNA-seq experiments. Cell suspensions were
loaded on a Chromium Single Cell Controller (10x
Genomics) to generate single-cell gel beads in
emulsion (GEMs) by using Single Cell 3' Library and
Gel Bead Kit V3 (10x Genomics, Cat# 1000092) and
Chromium Single Cell A Chip Kit (10x Genomics,
Cat#120236) according to the manufacturer’s
protocol. Briefly, single cells were suspended in 0.04%
BSA–PBS. Cells were added to each channel, captured
cells were lysed, and the released RNA were barcoded
through reverse transcription in individual GEMs27.
GEMs were reverse transcribed in a C1000 Touch
Thermal Cycler (Bio Rad, Hercules, CA, USA)
programmed at 53 °C for 45 min, 85 °C for 5 min, and
held at 4 °C. After reverse transcription, single-cell
droplets were broken, and the single-strand cDNAs
were isolated and cleaned with Cleanup Mix
containing DynaBeads (Thermo Fisher Scientific).
cDNAs were generated and amplified, and the quality
was assessed using the Agilent 4200.

Single cell RNA-Seq library preparation
Single-cell RNA-seq libraries were prepared
using Single Cell 3’ Library Gel Bead Kit V3 following
the manufacturer’s guide (https://support.10x
genomics.com/single-cell-gene-expression/library-pr
ep/doc/user-guide-chromium-single-cell-3-reagent-k
its-user-guide-v3-chemistry). Single Cell 3’ Libraries
contain the P5 and P7 primers used in Illumina bridge
amplification PCR. The 10x Barcode and Read 1
(primer site for sequencing read 1) were added to the
molecules during the GEM-RT incubation. The P5
primer, Read 2 (primer site for sequencing read 2),
Sample Index and P7 primer were added during
library construction. The protocol was designed to
support library construction from a wide range of
cDNA amplification yields spanning from 2 ng to >2
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μg without modification. Finally, sequencing was
performed on an Illumina Novaseq6000 with a
sequencing depth of at least 100,000 reads per cell for
a 150 bp paired end (PE150) run.

Pre-processing of scRNA-seq data
Raw FASTQ files were mapped to the Reference
genome (GRCh38/hg38) using Cell Ranger 3.0
(https://support.10xgenomics.com/single-cell-geneexpression/software/pipelines/latest/what-is-cell-ra
nger). To create Cell Ranger-compatible reference
genomes, the references were rebuilt according to
instructions from 10x Genomics (https://www.10x
genomics.com), which performs alignment, filtering,
barcode counting and UMI counting. Following
alignment, digital gene expression (DGE) matrices
were generated for each sample and for all samples.
Merged 10x Genomics DGE files were generated
using the aggregation function of the Cell Ranger
pipeline. All cells in different batches were merged
and normalized by equalizing the read depth among
libraries. Only confidently mapped, non-PCR
duplicates with valid barcodes and unique molecular
identifiers were used to generate the gene-barcode
matrix (Figure S1A-B). For further quality control, we
excluded cells that had fewer than 150 detected genes.
We then calculated the distribution of genes detected
per cell and removed any cells in the top 2% quantile.
We also removed cells where >20% of the transcripts
were attributed to mitochondrial genes (Figure
S1C-D). After removing disqualified cells from the
dataset, the data were normalized by the total
expression, multiplied by a scale factor of 10,000, and
log transformed.

Dimensionality reduction and data
visualization
To visualize the data, we first calculated the ratio
of binned variance to mean expression for each gene
and selected the top 2,000 most variable genes. Next,
we performed principal component analysis (PCA)
and reduced the data to the top 20 PCs. Finally, we
performed non-linear dimensionality reduction for
the dataset to project the cells in 2D space based on
gene expression data of the highly variable genes
using t-SNE [28].

Clustering and differential gene expression
analysis
We performed a graph-based clustering of the
previously identified PCs using the Louvain Method
[29], and the clusters were visualized on a 2D map
produced with t-SNE. For each cluster, we used the
Wilcoxon rank-sum test to identify significantly
differentially expressed genes (DEGs) when
http://www.ijbs.com
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compared to the remaining clusters (Bonferroni
correction was used to adjust for multiple hypothesis
testing, adjusted p value < 0.05 was regarded as
significant, paired tests when indicated). To visualize
how well the cluster-specific DEGs (marker genes)
defined each cluster, we constructed the violin plot,
feature plot (tSNE plot colored by expression level of
indicated genes), and heatmap (top 10 genes with
highest average log-transformed fold change – logFC)
using the Seurat R packages [30,31].

Pathway enrichment analysis and trajectory
analysis
To investigate the biological processes and
signaling pathways associated with each cluster
(subtype), we performed GO and KEGG enrichment
analysis on the identified cluster-specific DEGs by
using the clusterProfiler R package [32]. To visualize
the results, we used the ComplexHeatmap and GOplot R
packages. We then applied Monocle for trajectory
inference and pseudotime analysis [33,34]. The
principle of these analyses is to determine the pattern
of the dynamic process experienced by the cell
population and to order the cells along their
developmental trajectory based on differences in the
expression profiles of highly variable genes.

Cross-species scRNA-seq data integration
Two previous independent scRNA-seq datasets
of mBM-MSCs were acquired from GEO database
under the accession numbers of GSE128423 and
GSE108892, respectively [7,19]. After acquiring the
expression matrix, cells expressing LEPR were
isolated as the LEPR+ mBM-MSC subset. We then
applied canonical correlation analysis (CCA) to the
top 2,000 genes with the highest dispersion shared
between datasets using the Seurat alignment method
to integrate scRNA-seq data of hBM-MSCs and
mBM-MSCs [30,31]. The CCA method identifies
shared correlation structures across different datasets
by finding linear combinations of the features that
have large correlation. Finally, we aligned the
subspaces based on the first 30 canonical correlation
vectors, resulting in reduced dimensionality for
further analysis [7]. The batch effect was then assessed
based on the correlation of average gene expression
between the datasets.

Results
Cellular heterogeneity of the human CD271+
BM-MNCs
To study the transcriptomic diversity of the
BM-MSCs, we applied scRNA-seq on freshly isolated
CD271+ BM-MNCs from the femoral shaft-derived
bone marrow of two human subjects (one with

4196
osteoporosis and the other with osteoarthritis) (Figure
1A). Cells were affinity isolated with CD271
conjugated magnetic microbeads (see methods), and
mRNA libraries were prepared and sequenced with
the 10x Genomics Chromium system. After quality
filtering (Figure S1A-C), we obtained an expression
matrix of 14,494 cells where transcripts for the average
number of genes detected per cell was 1,363. There
was a strong correlation between the overall gene
expression profiles of the two subjects (R = 0.96,
Figure S1D-E), and therefore we combined the data
from the two subjects for subsequent analyses. The
graph-based clustering divided the cells into 15
distinct clusters (clusters A-O), and the differentially
expressed genes (DEGs) of each cluster were
identified with the Wilcoxon rank-sum test (Figure
S2A-B; Table S1 Sheet 1).
Among the cell type clusters, clusters C and D
expressed high levels of BM-MSC marker genes,
including LEPR (leptin receptor), NGFR (CD271),
ENG (CD105), THY1 (CD90), and NT5E
(CD73).
Notably, LEPR had the strongest expression levels
(Figure S2C). The remaining clusters are PTPRC
(CD45)
or
HBA1
(hemoglobin-1)
positive
hematopoietic cells (Figure S2C). Specifically, based
on the identified markers: 1) clusters A and B are
CD11b/16/66bhi neutrophils; 2) clusters F, K, and N
are CD14hiCD16low/hi monocytes; 3) clusters E, I, L,
and M are CD19hi B cells; 4) cluster H is CD3hi T cells;
5) cluster O is CD56hi NK cells; and 6) clusters G and J
are HBA1hi nucleated red blood cells (RBCs) (Figure
1B; Table S1 Sheet 1). These findings are consistent
with previous reports that MSCs are the main source
of LEPR expression in human bone marrow and
CD271+ MNCs also express certain levels of CD45
(Figure S2C) [6,35]. By comparing the gene expression
pattern between LEPRhiCD45low BM-MSCs and other
CD45hi hematopoietic cells, we discovered several
potential surface markers for isolation of human
BM-MSCs such as high expression of CD167b, CD91,
CD130, CD118 and low expression or absence of
CD74, CD217, CD148, CD68 (Table S1 Sheet 2). These
results demonstrate that CD271+ MNCs are a
heterogeneous cell population containing several cell
types.

Cellular taxonomy of BM-MSCs
To investigate the cellular heterogeneity within
BM-MSCs, we extracted LEPR+CD45- cells (clusters C
and D, Figure S2A) from the original dataset for
further analyses. The LEPR+CD45- BM-MSCs were
divided into six distinct groups by an unbiased
clustering analysis (Figure 1C and S2D). Based on
known cell markers or functional genes, the different
subtypes of BM-MSCs were annotated as: 1)
http://www.ijbs.com
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osteoblast precursor (cluster C1, expressing
osteogenic markers including collagen 1 and ALPL
[36,37]); 2) adipocyte precursor (cluster C2, expressing
adiponectin and MGP [38,39]); 3) chondrocyte
precursor (cluster C6, expressing CD56 and WIF1
[14,40]); and 4) terminal-stage cells that do not express
differentiation markers (clusters C3-C5) (Figure 1D).
We studied the expression and function of the
cluster-specific DEGs in the new BM-MSCs
subpopulations (Figure 1D, Table S1 Sheet 3) and
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found several interesting results. 1) Besides known
markers or functional genes such as ALPL and
collagen 1, some novel genes were also highly
expressed in the osteoblast precursor cells. For
instance, MCAM (CD146) was differentially
expressed in osteoblast precursors when compared
with other cell subtypes. CD146 was recently reported
as one of the markers for human osteoblast precursors
[15]. 2) Along with ADPQ (adiponectin) and MGP,
APOD (apolipoprotein D) was also highly expressed

Figure 1. scRNA-seq analysis of human BM-MSCs. (A) Schematic summarizing an overview of the study. (B-C) t-SNE visualization of color-coded clustering of 14,494
human CD271+ BM-MNCs. The labeled texts indicate the individual clusters. Dashed lines in (B) delineate LEPRhiCD45low BM-MSCs, which are further classified into subgroups
shown in (C). The upper-right t-SNE plot in (C) shows the difference in BM-MSCs between the two subjects. (D) Violin plots showing relative expression levels of selected
cluster-specific marker genes for osteoblast (top row), chondrocyte (middle row), and adipocyte (bottom row) precursors, respectively. (E-F) GO (E) and KEGG (F)
enrichment analyses for osteoblast, chondrocyte, and adipocyte precursors. Dot plot shows the most significant terms. The size of dot indicates the gene ratio (enriched genes/
total number of genes). The color indicates the adjusted p value for enrichment analysis. Dashed boxes highlight the terms related to MSC functions.
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Int. J. Biol. Sci. 2021, Vol. 17
in the adipocyte precursors. 3) Osteomodulin (OMD)
was highly expressed in the chondrocyte precursors.
Previous reports have shown that OMD induces
endochondral ossification through PI3K signaling,
and regulates the extracellular matrix during bone
formation by reorganizing collagen fibrils and
increasing aggrecan expression in chondrocytes
[41-43]. Taken together, the findings suggest that
OMD may potentially regulate chondrogenic
differentiation.
To study the shared and distinct biological
processes between different cell type clusters, we
performed GO and KEGG functional term enrichment
analysis of DEGs in osteoblast, chondrocyte, and
adipocyte precursors (Table S2). Several enrichment
terms for bone development were detected in the
osteoblastic and chondrocyte precursors including
“ossification”, “osteoblast differentiation”, etc. The
adipocyte precursors were enriched for terms such as
“non-alcoholic
fatty
liver
disease”
and
“thermogenesis” (Figure 1E-F) [44,45]. These results
demonstrate that human BM-MSCs consist of a
heterogeneous cell population with several different
subtypes, which are characterized by distinct
biological processes.
In contrast, the remaining subgroups (clusters
C3-C5) of the BM-MSCs did not express any
differentiation markers, and the GO enrichment
analyses did not detect any significant terms related
to differentiation processes. Members of ribosomal
protein (RP) gene family, which encodes
ribonucleoprotein, were highly expressed in clusters
C3 and C4 (Table S1 Sheet 3). Previous evidence
suggests that the expression of ribonucleoprotein is
required for maintenance of self-renewal potency of
stem cells [46]. These clusters were enriched for GO
terms
related
to
ribonucleoprotein,
RNA
degeneration, and cell apoptosis (Figure S3A). These
results partially support the claim that these clusters
contain cells at terminal stage which lack the capacity
for cellular differentiation. We noted that although
cluster C5 had high expression levels of LEPR, a small
fraction of the cells in this group also expressed low
levels of CD45 and were enriched for immune cell
related terms such as “neutrophil cell activation” and
“leukocyte migration” (Figure S2E and S3A). This
suggests that CD45+ immune cells may have
contaminated this cluster, and therefore we excluded
this cluster (C5) from further analysis.

Dynamic gene expression patterns at different
developmental stages of BM-MSCs
In order to better understand the differentiation
relationships between BM-MSCs subtypes, we
reconstructed the developmental trajectory by
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inferring the dynamic gene expression patterns at
different developmental stages. The estimated
developmental trajectory showed multiple branches,
representing
the
multi-lineage
differentiation
potential of BM-MSCs (Figure 2A). By comparing the
distribution of the cell population along the
pseudotime, we found that osteoblast precursors
(cluster C1) were more enriched in the early stage of
pseudotime compared with the other clusters, while
adipocyte and chondrocyte cells were evenly
distributed along the pseudotime (Figure 2B).
Pseudotime ordering of cell type clusters revealed a
continuum of gene expression between the early and
late stages of BM-MSC differentiation (Figure 2C).
When the dynamic gene expression patterns between
osteoblast and adipocyte markers were compared, the
osteoblast markers decreased over pseudotime, while
the adipocyte markers remained unchanged or
increased (Figure 2D). These findings suggest that
osteoblast precursors are only differentiated at the
early stage of BM-MSC development, while
adipogenesis is continuous across different stages. We
also noticed that clusters C3 and C4 were mostly
represented at the later stage of the pseudotime
(Figure 2B). By analyzing the gene expression pattern,
we found that G2M genes [47] were expressed at
lower levels in these two clusters (Figure 2E).

Osteoblast precursors induce angiogenesis
during coupling with osteogenesis
Previous studies have reported that osteoblasts
may regulate angiogenesis [48,49], but this
phenomenon has not yet been explored at the
single-cell level. Interestingly, transcripts for some
secreted factors associated with the vascular system
(e.g., VCAN and ANGPTL4 [50,51]) were highly
expressed in the osteoblast precursors, (Figure 3A).
This result suggests that osteoblast precursors may
induce angiogenesis concurrently with osteogenesis.
In supporting this, the cluster marker genes of
osteoblast precursors were enriched for not only
osteogenesis related GO terms, but also for functional
processes related to angiogenesis such as “regulation
of vasculature development” and “positive regulation
of angiogenesis” (Figure 1E and 3B). We further
investigated the genes enriched for these biological
processes and identified 32 genes regulating
osteogenesis (e.g., COL1A1/A3, COL6A1/A3,
VCAN, IGFBP3, etc.), 16 genes for angiogenesis (e.g.,
ADM, EGR1, NGFR, etc.), and 11 shared genes
including MDK, JUNB, ENG, IGTB2, APOB, etc.
(Figure 3C; Table S3 Sheet 1). Among these genes,
some have a much higher expression level in the
osteoblast precursors compared with other cells.
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Figure 2. Dynamic gene expression patterns of human BM-MSCs. (A) Reconstructed principal component graph of cell differentiation trajectory of BM-MSCs, colored
by subpopulation identities. The upper-right trajectory plot in the square indicates the direction of pseudotime. (B) Distribution of each cell subpopulation along the pseudotime.
(C) Continuum of dynamic gene expression in pseudotime of BM-MSCs. Heatmap shows top 50 genes with most significant expression changes. Pixel color indicates the
expression level (logFC). (D) Expression level of osteogenic (top) and adipogenic (bottom) genes with respect to pseudotime coordinates. Blue lines depict the LOESS regression
fit of the normalized expression values. (E) Expression pattern of G2M genes of BM-MSCs.

Notably, we found that MDK, CD105, and
ADAMTS9 were highly expressed and frequently
enriched in multiple functional terms related to
osteogenesis and angiogenesis (Figure S3B). It has
been shown that MDK is positively associated with
angiogenesis while inversely associated with
osteogenesis [52,53], potentially via MAPK and PI3K
signaling [54]. High expression of CD105 has been
shown to disrupt angiogenesis in tumor tissue, and
CD105- BM-MSCs are more prone to differentiate into
adipocytes and osteocytes [11,55]. ADAMTS9 is
expressed during ossification and also may regulate
angiogenic signaling induced by VEGF [56,57]. Our
results together with the previous evidence suggest
that the co-regulation of osteogenesis and
angiogenesis by osteoblast precursors is a complex
network involving multiple genes whose regulatory

effects are sometimes in opposite directions.
The KEGG pathway analysis revealed that the
osteogenesis and angiogenesis genes were enriched in
the PI3K-Akt, MAPK, Rap1, AGE-RAGE, Relaxin, and
TNF signaling pathways, in which PI3K-Akt signaling
had the most genes enriched (Figure 3D). The genes
COL1A1, PGF, and JUN were highly expressed and
were also enriched in multiple pathways, indicating
that these genes may be essential in the various cell
signaling networks. We also found that PI3K-Akt
signaling and osteogenesis share a large proportion of
common genes, suggesting that this pathway may
have a significant role in regulating osteogenesis of
BM-MSCs (Figure 3E). On the other hand, the MAPK,
PI3K-Akt, and Rap1 signaling pathways share
comparable proportions of genes with angiogenesis
(Figure 3E). Furthermore, COL4A2, HGF, IGBT1, and
http://www.ijbs.com
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ID1 are essential factors connecting the genetic
network between the different pathways and
biological processes (Figure 3F). These results suggest
that osteogenesis and angiogenesis in osteoblast
precursors are likely mediated by multiple genes and
pathways, and particularly through PI3K-Akt
signaling pathways.

Myogenesis potential of CD56+ chondrocyte
precursors
To partially confirm the existence of the CD56+
BM-MSCs, we performed flow cytometry analysis on
murine bone marrow derived cells. The result
confirmed that CD56+ fraction makes up about 8% of
the total BM-MSCs (Figure 4A). Confocal
immunofluorescence imaging of murine femur
further demonstrated that CD56+ BM-MSCs
(Lepr+CD56+ cells) were mainly located at the growth
plate (Figure 4B and S3E). The DEGs in CD56+
chondrocyte precursors were enriched in GO terms
related to both chondrogenesis (e.g., “cartilage
development”, “chondrocyte differentiation”) and
myogenesis (e.g., “muscle cell differentiation”,
“myoblast differentiation”) (Figure 4C). There were
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46 DEGs enriched in terms related to chondrogenesis
(e.g., IBSP, SPP1, A2M, IGTA10, etc.), 42 for
myogenesis (e.g., ACTA2, ADARB1, CD9, VIM, etc.),
and 13 shared genes for both processes (e.g., NPNT,
MEF2C, ITGA8, TGFB1, etc.) (Figure 4D and S3C).
Based on the KEGG pathway analysis, we
determined that DEGs in the chondrocyte precursors
were enriched in the PI3K-Akt, MAPK, Ras, Rap1,
TGF-beta, Apelin, and Hippo signaling pathways
(Figure 4E). TGF-beta signaling shared the largest
number of genes with chondrogenesis, while the
genes enriched in Apelin and Ras/Rap1 signaling
overlapped mostly with myogenesis (Figure S3D). By
investigating the overlapping genes between
biological processes and signaling pathways, we
found that FGFR1 and TGFB1 may be crucial genes
connecting multiple pathways to both chondrogenesis
and myogenesis (Figure 4F). Thus, the CD56+
chondrocyte precursor of the BM-MSC subpopulation
is capable of both chondrogenesis and myogenesis,
and these processes may be regulated by the
TGF-beta, Apelin, and Ras/Rap1 signaling pathways.

Figure 3. Functional analysis for ALPLhi osteoblast precursor. (A) Violin plots showing relative expression levels of VCAN and ANGPTL4. Osteoblastic cluster was
highlighted by the red box. (B) Enriched GO terms associated with osteogenesis (top) and angiogenesis (bottom) in osteoblast precursors. Bar chart shows the number of genes
enriched in each term. Color indicates the adjust p values. (C) Differential expression of osteogenesis- and (or) angiogenesis-related genes (rows) in osteoblast precursors
compared to the other cells. Heatmap shows top 10 most significant DEGs in each category, where color indicates the relative expression levels between osteoblast precursors
and other cells (z-score). (D) Gene expression pattern in enriched pathways. Squares show enriched DEGs in the corresponding terms (rows). Color indicates the expression
value of the DEGs (average logFC). (E-F) Table of genes in biological processes and pathways. (E) Numbers outside the circles indicate the number of genes in that term. Width
of curves connecting different terms is proportional to the number of shared genes. (F) Table of the specific genes enriched in each biological process and pathway.
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Figure 4. Functional analysis for CD56hi chondrocyte precursor. (A) Flow cytometry dot plot showing proportion of CD56+ BM-MSC fraction in mouse. (B)
Representative confocal immunofluorescent imaging showing distribution of Lepr+CD56+ BM-MSCs in murine femur at low (left) and high (right) magnification. Arrows marked
Lepr+CD56+ cells (C) Enriched GO terms associated with chondrogenesis (top) and myogenesis (bottom) in chondrocyte precursor cells. Bar chart shows the number of
enriched genes in each term. Color indicates the adjust p values. (D) Differential expression of chondrogenesis- and (or) myogenesis-related genes in chondrocyte precursors
compared to the other cells. Dot plot shows top 10 most-significant DEGs in each category (Middle: Chondrogenesis; Bottom: Myogenesis; Top: Common for both), where dot
color indicates the relative expression levels between chondrocyte precursors and other cells (z-score) and the dot size shows the proportion of cells expressing the indicated
genes. (E) Gene expression pattern in enriched pathways. Squares show enriched DEGs in the corresponding terms (rows). Color indicates the expression value of the DEGs
(average logFC). (F) Table of genes in biological processes and pathways.

Transcriptional difference between human and
mice BM-MSCs at single-cell level
To investigate the difference of transcriptional
profiles between BM-MSCs acquired from humans

and mice (hBM-MSCs, mBM-MSCs, respectively), we
integrated our single-cell human transcriptome data
with two previous scRNA-seq studies of bone
marrow components in mice [7,19]. Potential batch
effects among different studies were reduced by
http://www.ijbs.com
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canonical correlation analysis (CCA) (see methods)
[58,59], and the transcriptomic profiles from different
datasets had high correlation (Figures 5A-C and
S4A), suggesting that after the CCA integration, the
batch effects between different studies were relatively
small and were, therefore, unlikely to introduce
notable bias into the downstream analysis.
To test whether heterogeneity exists between
human and mice BM-MSCs, the integrated crossspecies data were analyzed by an unbiased clustering.
hBM-MSCs and mBM-MSCs were separated into
different clusters (osteogenic, chondrogenic, adipogenic, and terminal in human; m1-m4 in mice) (Figure
5B). We also observed significant differences in the
gene expression pattern between human and mice
BM-MSCs at single-cell level (Figure 5D, Table S1
Sheet 4). The clustering and gene expression results
suggested that even though the overall data had a
large correlation based on average gene expression,
there were still systematic differences between
hBM-MSCs and mBM-MSCs transcriptomes at the
single-cell level. There was a strong correlation
between the average gene expression of subtypes in
hBM-MSCs and mBM-MSCs except for human
chondrogenic BM-MSCs (Figure 5E). This observation

4202
suggests that the overall gene expression pattern and
differentiation trajectory of hBM-MSC derived
chondrocyte precursors is less similar with those in
the mBM-MSCs, when compared to other hBM-MSC
subpopulations.
Human and mice BM-MSCs often present
different cell surface markers [3]. Consistent with this
result, by comparing the DEGs between hBM-MSCs
and mBM-MSCs, we revealed several CD markers
with distinct expression patterns between human and
mice BM-MSCs. For instance, CD317, CD36, and
CD63 were highly expressed in hBM-MSCs, but not in
mBM-MSCs; and vice versa for CD148, CD108, and
CD20 (Figure S4B).

Discussion
While a growing body of evidence indicates that
BM-MSCs have a central role in bone health, the
underlying subtypes of BM-MSCs, especially in vivo in
humans, remains largely unknown due to its
heterogeneous characteristics. In the present study,
we applied scRNA-seq analysis on freshly isolated
human BM-MSCs and their niche hematopoietic cells.
The use of freshly isolated human cells is a major
advantage of this study, since any form of extra in

Figure 5. Integrated cross-species analysis between human and mouse BM-MSCs. (A-B) t-SNE visualization of human and mouse BM-MNCs before (A) and after (B)
CCA integration. The labeled texts indicate the datasets or subpopulations identified by clustering analysis. Human (h): data from this study; mice1 (m): data from Tikhonova et
al. [7]; mice2 (m): data from Baryawno et al. [19]. (C) Correlations of gene expression among human and mouse BM-MSCs after CCA integration. Each dot represents an
individual gene. Texts indicate highly expressed genes shared between the two species. The average gene expression level is plotted for each subject. Correlations were measured
by Pearson correlation coefficients (R, p < 0.01). (D) Gene signature of human and mouse BM-MSCs, based on the relative gene expression level of top 20 most-significant DEGs
for each species (z-score). (E) Correlations of gene expression between different subsets of human and mouse BM-MSCs identified by clustering analysis (Osteogenic,
chondrogenic, adipogenic and terminal in human; m1-m4 in mice). Values in the table represent the Pearson correlation coefficients (R, p < 0.01). (F) Enriched signal pathways
(KEGG terms) of human (top) and mice (bottom) BM-MSCs. Bar chart shows the number of enriched genes in each term.
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vitro operations (e.g., freezing, culturing) could
potentially alter the true transcription pattern [22] and
thus lead to biased cell clustering/identification. In
addition, our results along with previous evidence
have highlighted that transcription profiles vary to a
large degree between humans and mice [23].
Several studies have applied scRNA-seq on bone
marrow stroma components or MSCs derived from
various origins (e.g., bone marrow, adipocytes,
umbilical cord). For instance, Tikhonova et al. [7] and
Baryawno et al. [19] independently performed
scRNA-seq on bone marrow stroma components
(including BM-MSCs, vasculature, osteoblastic cells,
etc.). Similar to their results, we also identified
subtypes corresponding to multiple trajectories in
BM-MSCs. Chan et al. [15,16], on the other hand,
identified skeletal stem cells in humans and mice.
They also demonstrated a Lin-PDPN-CD146+
osteogenic subset that only gives rise to osteoblasts/
osteocytes [15]. Similarly, we found that CD146 was
differentially expressed in the osteogenic subset of
BM-MSCs. Some studies also performed scRNA-seq
on cultured human MSCs derived from various
origins [20,21,62], but none of these studies focused on
subtype identification. Compared with those studies
that focused on mouse cells or in vitro cultured human
cells, our results thus greatly expand the
understanding of in vivo human BM-MSCs by
presenting unbiased transcriptional profiles of
distinct
subpopulations
including
osteoblast,
chondrocyte and adipocyte precursors as well as
other components of the human BM-MSC cell
population in vivo.
Although the use of freshly isolated cells for
scRNA-seq may preserve to the largest extent the
accuracy of the transcriptomic profile, this approach
also limits the total number of collected cells.
Therefore, we used a single marker – CD271 – for
positive sorting, instead of combining with
CD45-negative selection, which would generate even
less yield. Based on the scRNA-seq gene expression
profiles, we demonstrated that the CD271+ BM-MNCs
represent a heterogeneous cell population, which may
be subdivided into BM-MSCs along with various
hematopoietic cells that contribute to the formation of
niche components. Our finding suggests that the
BM-MSC isolation protocol based solely on positive
selection is not ideal as the isolated cells consist of
various cell types. Instead, positive selection
combined with negative selection using CD45 or
lineage markers (LIN) should be considered if the
major purpose is to isolate BM-MSCs with a higher
purity [5,63].
Interestingly, though we used CD271 as the cell
surface marker for BM-MSC positive selection, the
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gene expression of CD271 was lower than expected
(Figure S2C), suggesting that the protein expression
may not be associated with the expression of the
corresponding gene. Previous single-cell studies also
showed similar results. For instance, Qin et al.’s
results [64,65] showed that even after positive
selection of Col2+ cells by FACS sorting, the single-cell
gene expression of Col2 (Col2a1) is lower than
expected. It is well known that the abundance of
expressed proteins cannot always be inferred directly
from mRNA readout alone [66]. New single-cell
techniques have emerged which can simultaneously
evaluate gene expression at both transcript and
protein level, which may provide a more accurate
characterization of cellular identity, states, and
function [67].
Since BM-MSCs are heterogeneous for several
existing cell markers [7,9], it is necessary to search for
novel BM-MSC-specific cell markers (specifically and
uniformly expressed in the major BM-MSC
populations). By comparing the expression pattern
between BM-MSCs and other niche hematopoietic
cells, we confirmed the expression of classic cell
markers including CD271, LEPR, CD105, and CD90 at
the single-cell level. Notably, we found that LEPR had
the highest expression level and was specific to the
BM-MSC population, which is consistent with the
results from mouse models [35]. We also detected
some additional specifically expressed CD markers
(e.g., CD167b, CD91, CD130, CD118) in BM-MSCs,
which may potentially serve as novel surface markers
for BM-MSC enrichment/purification.
A systematic analysis of the BM-MSC transcriptional profiles revealed distinct subpopulations
corresponding to osteogenic, chondrogenic, and
adipogenic differentiation, as well as terminal-stage
cells in the quiescent state. Further examination into
the relationships between the highly expressed genes,
biological processes, and signaling pathways in each
subpopulation suggests that osteoblast precursors
may have the capacity to induce vasculature
development, and the chondrocyte precursors may
have myogenic potential. Normally, the coupling of
osteogenesis and angiogenesis is in the same
regulation direction, i.e., vascular development will
promote bone formation and vice versa [68]. However,
several recent studies have already shown that in
some cases the regulatory effect of these two
biological processes could be opposite. For instance,
even though VEGF stimulates vascularization, high
amounts of VEGF could impair bone formation [69].
Similar patterns were found in BM-MSCs in this study
where osteoblast precursors express CD105 and
MDK, whose regulatory effect on osteogenesis and
angiogenesis may be opposite, suggesting that the
http://www.ijbs.com
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coupling of osteogenesis and angiogenesis is a
complex regulatory network where both positive and
negative feedback may be included. It has been
proposed that bone and muscle act as secretory
endocrine organs affecting the function of one another
through various pleiotropic genes and signaling
pathways including (e.g., FGF-2, FGF-23, TGF-β,
Wnt-3a) [70-72]. Our results demonstrated similar
findings. For instance, we found that Wnt and TGF
pathways
may
have
important
roles
in
chondrogenic-myogenic crosstalk in BM-MSCs. We
also found that FGF receptor may contribute to the
crosstalk through various pathways such as MAPK
and Ras.
Some interesting results were discovered when
we analyzed the subtypes of BM-MSCs in-depth. We
found that APOD was highly expressed in the
adipocytic subtypes. Although APOD has not
previously been linked to adipogenesis, other
apolipoproteins, such as APOA and APOE [73,74] are
known to modulate adipocyte metabolism. Therefore,
it is conceivable that APOD may also regulate
adipogenesis. We found that G2M genes were less
expressed in the terminal stage BM-MSCs. Although
this result somewhat suggested that the terminal cells
might be quiescent stem cells, the stem cell markers
were not differentially expressed in terminal cells.
Therefore, the identity of terminal cells remains
elusive, and worth further investigation. The
scRNA-seq profiles of the BM-MSCs also revealed a
continuum of dynamic gene expression pattern,
indicating that osteogenesis occurs only at the early
stages of BM-MSC development while the adipogenic
and quiescent cells take a dominant place in the
terminal stages (Figure 2B). These findings suggest
that aging of BM-MSCs represents an important factor
in the balance between the osteogenic and adipogenic
differentiation.
Although emerging studies have explored the
single-cell transcriptome of both human and mouse
BM-MSCs, few have considered the cross-species
difference of transcriptome between h/m-BM-MSCs.
Several studies have described such differences in
other tissues at single-cell level [75,76]. By integrating
our hBM-MSCs data with previous scRNA-seq data of
mBM-MSCs, we were able to systematically analyze
the shared and specific features of h/m-BM-MSCs.
The findings suggest that some features are conserved
across species, such as the high expression of Cxcl12,
while other features such as the surface markers and
genes regulating osteo-/adipo-genesis may be
different. Understanding the systematic differences
between h/m-BM-MSCs is essential, especially when
attempting to adapt the conclusions from mouse
models to humans or vise versa.
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We also note some limitations of our study
design. Firstly, these findings are based on
bioinformatic analysis of single-cell transcriptome,
and without further molecular validations, some of
these results are suggestive rather than conclusive,
such as proposed cell markers or differentiation
potentials. Other limitations of this study include
batch effect and sample size. While the overall data
did not show a significant batch effect, the
transcription pattern of the BM-MSCs varied between
the two human subjects (Figure S2D). We
hypothesize that this may be explained by the gender
and age differences. However, with limited sample
size, it is difficult to deduce whether and/or how such
differences are related to the disease status (e.g.,
osteoporosis vs. osteoarthritis) or other factors (e.g.,
age, gender, lifestyle, medical/medication history). In
future studies, more subjects should be included to
overcome potential batch effects and to explore how
different health states and other factors affect the bone
marrow microenvironment.
Despite providing a detailed characterization of
human BM-MSCs at single-cell resolution, the full
trajectory of the osteoblastic lineage cells, as well as
their balance and interaction with the osteoclastic
lineage remain elusive. In our future studies, by
combining scRNA-seq with scATAC-seq – a powerful
tool to evaluate chromatin accessibility at the
single-cell level, we will aim to unveil the complexity
of osteoblastic-osteoclastic lineage interactions and
gene expression regulations within/between the two
lineages. In the meantime, deconvoluting the
heterogeneity of BM-MSCs in vivo in humans
represents an important and necessary advancement
towards improving our understanding of bone
physiological processes.
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